Drugs / [89Zr]Zr-DFO-APAC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06204237 | Feb 2024 → Jun 2025 overdue | limb ischemia, peripheral arterial occlusive disease 1 | Aplagon Oy | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [89Zr]Zr-DFO-APAC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06204237 ↗ |
| Route | Intravenous | “single i.v. injection” NCT06204237 ↗ |